06 February 2024 : Clinical Research
Arterial Stiffness and Ankle-Brachial Index – Cross-Sectional Study of 259 Primary Care Patients ≥50 Year-Old
Anna KamieńskaDOI: 10.12659/MSM.942718
Med Sci Monit 2024; 30:e942718
Table 4 LEAD risk factors, clinical symptoms, signs, and pulse wave velocity (PWV) measurements.
| LEAD risk factor or clinical symptom or sign or symptom N-266 N (%) | PWV | Spearman’s (p, r) | PWV | Spearman’s (p, r) | ||
|---|---|---|---|---|---|---|
| >uPWVt | ≤uPWVt | >iPWVt | ≤iPWVt | |||
| Hypertension | 78 (45.3) | 77 (44.8) | 95 (55.2) | |||
| Diabetes mellitus | 29 (69.1) | 13 (30.9) | 22 (52.4) | 20 (57.6) | 0.052, r=12 | |
| Elevated blood pressure | 56 (64.4) | 31 (35.6) | 61 (70.1) | 26 (29.9) | 0.161, r=0.16 | |
| Current/former smoking | 93 (48.2) | 100 (51.8) | 0.134, r=−0.09 | 73 (37.8) | 120 (62.2) | 0.366, r=−0,06 |
| Edinburgh Claudication Questionnaire positive result | 15 (57.7) | 11 (42.3) | 0.131, r=0.09 | 10 (38.5) | 16 (61.5) | 0.336, r=0.06 |
| Absence of right posterior tibial pulse | 11 (73.3) | 4 (26.7) | 11 (73.3) | 4 (26.7) | ||
| Absence of left posterior tibial pulse | 12 (85.7) | 2 (14.3) | 8 (57.1) | 6 (42.9) | 0.153, r=−0.09 | |
| uPWVt – universal fixed PWV threshold >10 m/s; iPWVt – individualized PWV threshold calculated by the device; LEAD – lower-extremities arterial disease; r – Spearman’s rho correlation value. | ||||||






